STOCK TITAN

Covista CEO Stephen W. Beard sells 8,306 shares

Both sales followed a Rule 10b5-1 plan adopted December 10, 2025, and involved shares above Covista’s ownership and holding requirements.

(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Covista Inc. Chairman & CEO Stephen W. Beard sold 3,639 shares on October 8, 2026, at a weighted average price of $130.3690 per share, and 4,667 shares on October 9, 2026, at a weighted average price of $130.7690 per share. Both sales were made under a Rule 10b5-1 trading plan adopted on December 10, 2025. The reported footnotes state the shares came from holdings above Covista’s Stock Ownership and Holding Requirements and were sold in pre-scheduled increments.

Insights

Analyzing...

Insider Beard, Stephen W.
Role Chairman & CEO
Sold 8,306 shs ($1.08M)
Type Security Shares Price Value
Sale Common Stock F1, F2, F3, F5 4,667 $130.769 $610K
Sale Common Stock F1, F2, F3, F4 3,639 $130.369 $474K
Holdings After Transaction: Common Stock — 469,158 shares (Direct)
Footnotes (5)
  1. F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum.
  2. F2. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan.
  3. F3. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception.
  4. F4. This transaction was executed in multiple trades at prices ranging from $130.005 to $131.042. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. F5. This transaction was executed in multiple trades at prices ranging from $130.01 to $131.37. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares sold 3,639 shares October 8, 2026
Weighted average sale price $130.3690 per share October 8, 2026
Shares sold 4,667 shares October 9, 2026
Weighted average sale price $130.7690 per share October 9, 2026
Shares sold across reported transactions 8,306 shares Two sales on October 8 and October 9, 2026
Rule 10b5-1 trading plan regulatory
"effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sales price financial
"reflects the weighted average sales price"
Stock Ownership and Holding Requirements technical
"excess of Covista's Stock Ownership and Holding Requirements"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CVSA shares did Stephen W. Beard sell, and at what prices?

Stephen W. Beard sold 3,639 shares on October 8, 2026, at a weighted average of $130.3690 per share, and 4,667 shares on October 9, 2026, at a weighted average of $130.7690 per share.

What price ranges were reported for Stephen W. Beard’s CVSA sales?

The October 8 sale was executed at prices ranging from $130.005 to $131.042; its reported weighted average was $130.3690 per share. The October 9 sale was executed at prices ranging from $130.01 to $131.37; its reported weighted average was $130.7690 per share.

When was the Rule 10b5-1 plan for Stephen W. Beard’s CVSA sales adopted?

The Rule 10b5-1 trading plan was adopted on December 10, 2025, in accordance with Covista’s Insider Sales and Ownership Policy Addendum.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Beard, Stephen W.

(Last)(First)(Middle)
233 S. WACKER DRIVE
SUITE 800

(Street)
CHICAGO ILLINOIS 60606

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Covista Inc. [ CVSA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chairman & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)10/08/2026S(2)3,639(3)D$130.369(4)473,825D
Common Stock(1)10/09/2026S(2)4,667(3)D$130.769(5)469,158D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025 in accordance with Covista's Insider Sales and Ownership Policy Addendum.
2. Shares sold represent a portion of holdings in excess of Covista's Stock Ownership and Holding Requirements and were executed in pre-scheduled increments under the trading plan.
3. No discretionary trades by the reporting person are permitted under Covista policy; all sales must occur pursuant to a pre-established Rule 10b5-1 trading plan absent a hardship exception.
4. This transaction was executed in multiple trades at prices ranging from $130.005 to $131.042. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
5. This transaction was executed in multiple trades at prices ranging from $130.01 to $131.37. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Lawrence C. Bachman, attorney-in-fact for Mr. Beard10/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading